Literature DB >> 16116162

Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase.

Louise M C Webb1, Elena Vigorito, Matthias P Wymann, Emilio Hirsch, Martin Turner.   

Abstract

The role of PI3K activity in T lymphocyte development is obscure because mice deficient in single PI3K catalytic subunits either die before birth (p110alpha-/- and p110beta-/-) or lack a significant T cell developmental phenotype (p110gamma-/- and p110delta-/-). We have generated mice deficient in both p110gamma and p110delta and show that p110gamma/delta-/- mice have a profound block in T cell development that occurs at the beta-selection checkpoint. We show that pre-TCR-induced signaling is significantly reduced in p110gamma/delta-/- thymocytes and that this results in a concomitant lack of proliferative expansion and increased apoptosis. The survival defect in p110gamma/delta-/- thymocytes is associated with increased levels of the pro-apoptotic molecule Bcl2 interacting mediator of cell death. This work demonstrates that PI3K activity is critical for T cell development and depends on the combined function of p110gamma and p110delta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116162     DOI: 10.4049/jimmunol.175.5.2783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

Review 3.  Phosphatidylinositol 3 Kinase δ Inhibitors: Present and Future.

Authors:  Jennifer R Brown
Journal:  Cancer J       Date:  2019 Nov/Dec       Impact factor: 3.360

Review 4.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.

Authors:  J S Oak; M P Matheu; I Parker; M D Cahalan; D A Fruman
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 6.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

7.  The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.

Authors:  Molly S Thomas; Jason S Mitchell; Christopher C DeNucci; Amanda L Martin; Yoji Shimizu
Journal:  J Leukoc Biol       Date:  2008-06-03       Impact factor: 4.962

8.  p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Authors:  Aurore Saudemont; Fabien Garçon; Hakim Yadi; Marta Roche-Molina; Nayoung Kim; Anne Segonds-Pichon; Alfonso Martín-Fontecha; Klaus Okkenhaug; Francesco Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 9.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4.

Authors:  Michelle L Janas; Gabriele Varano; Kristjan Gudmundsson; Mamiko Noda; Takashi Nagasawa; Martin Turner
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.